BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indicationBy Nasdaq OMXMay 22, 2017, 12:11 PM UTC
BusinessAtlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indicationBy Nasdaq OMXMay 22, 2017, 12:11 PM UTC
BusinessAtlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indicationBy Nasdaq OMXMay 22, 2017, 12:11 PM UTC
BusinessAtlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indicationBy Nasdaq OMXMay 22, 2017, 12:11 PM UTC
BusinessAtlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indicationBy Nasdaq OMXMay 22, 2017, 12:11 PM UTC